Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #1 Aldeyra Therapeutuics; NDA Resubmission Reproxalap Plus Phase 2 Data Alcoholic Hepatitis 2nd Half Of 2024, Cash Beyond 2026 ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #1 is a biotech by the name of Aldeyra Therapeutics (ALDX). The reason why i want to go over this biotech ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #8 Kura Oncology; Positive Ziftomenib And 7+3 1st-Line AML Data, PDUFA Date November 30th 2025 Ziftomenib Established And ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #8 is a biotech by the name of Kura Oncology (KURA). The reason why I want to go over this biotech again ...
Fierce Biotech

Why Model Medicines needs to ‘discover new colors’ in its AI drug discovery quest

When Daniel Haders, Ph.D., was working in venture capital, he was on the hunt for an AI-driven drug discovery company that ...
Nasdaq

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
Wall Street Journal

Biotech Startups Use Models of Human Organs for Drug Discovery

Biotechnology startups are creating tiny models of human organs in an effort to speed the search for novel drugs. By devising more realistic models of human and disease biology, these startups aim to ...
Business Wire

Atelerix Enters Agreement with Cherry Biotech to Integrate Non-cryogenic Transport Solutions With Advanced Organoid Models

NEWCASTLE, England--(BUSINESS WIRE)--Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it ...